MIV Therapeutics, Inc. engages in the research, development, and commercialization of biocompatible coatings for stents, and other medical devices and drug delivery systems. It offers products for providing healing solutions for cardiovascular disease and other medical conditions. The company s pre-clinical development stage products include bare metal cardiovascular stents and drug-eluting cardiovascular stents. In collaboration with the University of British Columbia, the company developed coating technologies that utilize Hydroxyapatite for application on medical devices and drug delivery systems. The company is based in Vancouver, Canada.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for MIVI